Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Madharry who wrote (3804)	5/16/2001 8:40:19 AM
From: Biomaven	Respond to of 52153

Madharry, lower interest rates make future cash flows more valuable as they are discounted less True, but note that long term rates (which are the ones you use in DCF calculations) have not come down in the face of repeated short-term rate cuts by the Fed. In fact looking down my entire portfolio, currently my biggest single dollar loss based on original purchase price is on the 10-year Treasuries I bought a few months back. So much for investing in "safe" Treasuries instead of "risky" biotechs. <g> Peter